This Article Full Text Full Text (PDF) All Versions of this Article: 47/6/1155    most recent 01.HYP.0000222893.85662.cdv1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cameron, V. A. Articles by Winterbourn, C. C. Search for Related Content PubMed PubMed Citation Articles by Cameron, V. A. Articles by Winterbourn, C. C. Related Collections Congestive Genetics of cardiovascular disease Oxidant stress

(Hypertension. 2006;47:1155.)
© 2006 American Heart Association, Inc.

Original Articles

Angiotensin Type-1 Receptor A1166C Gene Polymorphism Correlates With Oxidative Stress Levels in Human Heart Failure

Vicky A. Cameron; Tessa J. Mocatta; Anna P. Pilbrow; Chris M. Frampton; Richard W. Troughton; A. Mark Richards; Christine C. Winterbourn

From the Christchurch Cardioendocrine Research Group (V.A.C., A.P.P., C.M.F., R.W.T., A.M.R.), Department of Medicine, and Free Radical Research Group (T.J.M., C.C.W.), Department of Pathology, Christchurch School of Medicine and Health Sciences, Christchurch, New Zealand.

Correspondence to Vicky Cameron, Department of Medicine, Christchurch School of Medicine and Health Sciences, 2 Riccarton Ave (or PO Box 4345), Christchurch 8001, New Zealand. E-mail vicky.cameron{at}chmeds.ac.nz

Oxidative stress plays a critical role in the pathogenesis of cardiovascular disease and diabetes. Studies in vascular cells and experimental animals have demonstrated that the angiotensin type-1 receptor (AT1R) contributes to formation of reactive oxygen species by activating nicotinamide-adenine dinucleotide phosphate oxidases, but the relevance of this pathway to human heart disease has not been established. Here we demonstrate that a polymorphism in the AT1R gene (A1166C), linked to increased receptor activity, is associated with elevated levels of oxidative stress markers in heart failure patients but not in healthy controls. Plasma protein carbonyls (PCs), a marker of oxidative protein modification, were 10-fold higher in heart-failure patients compared with controls [geometric means and 95% CIs for patients, 75 (57 to 100) pmol/mg; controls, 5 (4 to 7) pmol/mg; P<0.001]. Moreover, levels of PCs were 50-fold higher in patients homozygous for the polymorphism (CC) than in controls and significantly higher than the AA and AC genotype patient groups [CC: 273 (135–550); AC: 59 (35–98); AA: 65 (40–106) pmol/mg; P<0.001]. Levels of myeloperoxidase were also modestly increased in heart-failure patients [51 (46–57) ng/mL] compared with controls [37 (32–44) ng/mL; P<0.001], but were especially elevated in patients with a CC genotype [CC: 72 (58–89); AC: 52 (44–61); AA: 39 (34–46) ng/mL; P<0.001]. The AT1R genotype was demonstrated to be an independent predictor of both PCs and myeloperoxidase levels in heart-failure patients. These findings suggest that oxidative stress in human heart failure is regulated via angiotensin signaling and may involve the nicotinamide dinucleotide oxidase pathway.

Key Words: heart failure • oxidative stress • receptors, angiotensin

This article has been cited by other articles:

				M. M. Martin, J. A. Buckenberger, J. Jiang, G. E. Malana, G. J. Nuovo, M. Chotani, D. S. Feldman, T. D. Schmittgen, and T. S. Elton The Human Angiotensin II Type 1 Receptor +1166 A/C Polymorphism Attenuates MicroRNA-155 Binding J. Biol. Chem., August 17, 2007; 282(33): 24262 - 24269. [Abstract] [Full Text] [PDF]

				T. J. Mocatta, A. P. Pilbrow, V. A. Cameron, R. Senthilmohan, C. M. Frampton, A. M. Richards, and C. C. Winterbourn Plasma Concentrations of Myeloperoxidase Predict Mortality After Myocardial Infarction J. Am. Coll. Cardiol., May 22, 2007; 49(20): 1993 - 2000. [Abstract] [Full Text] [PDF]